Cue Biopharma(CUE)
BOSTON, MA
PharmaceuticalFocus: Immunotherapy
Cue Biopharma is a life sciences company focused on Immunotherapy.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
ImmunodeficiencyClinical Trials (1)
NCT05655546ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
N/ACUE-101
Head and Neck CancerClinical Trials (1)
NCT03978689A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1CUE-102
Recurrent GlioblastomaClinical Trials (1)
NCT06917885CUE-102 in Recurrent Glioblastoma
Phase 1CUE-102
Colorectal CancerClinical Trials (1)
NCT05360680A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Phase 1Phase 2
Clinical Trials (1)
NCT04852328Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Phase 2Phase 2
Clinical Trials (1)
NCT07172256CUE-101with Pembrolizumab for LA-HPV+HNSCCs
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 6 clinical trials
Top TAs: Oncology
SEC Filings: 2 available
Financials (FY2024)
Revenue
$5M341%
R&D Spend
$41M(743%)6%
Net Income
-$51MCash
$49M